Akt in cancer: Mediator and more

S Revathidevi, AK Munirajan - Seminars in cancer biology, 2019 - Elsevier
Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling
pathway. The Akt can be activated by a wide range of growth signals and the biochemical …

Long noncoding RNA in cancer: wiring signaling circuitry

C Lin, L Yang - Trends in cell biology, 2018 - cell.com
Long noncoding RNAs (lncRNAs), which are encoded by a vast less explored region of the
human genome, may hold missing drivers of cancer and have gained attention recently as a …

The phosphatidylinositol 3-kinase–AKT pathway in human cancer

I Vivanco, CL Sawyers - Nature Reviews Cancer, 2002 - nature.com
One signal that is overactivated in a wide range of tumour types is the production of a
phospholipid, phosphatidylinositol (3, 4, 5) trisphosphate, by phosphatidylinositol 3-kinase …

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions

PP Roux, J Blenis - Microbiology and molecular biology reviews, 2004 - journals.asm.org
Conserved signaling pathways that activate the mitogen-activated protein kinases (MAPKs)
are involved in relaying extracellular stimulations to intracellular responses. The MAPKs …

Cellular survival: a play in three Akts

SR Datta, A Brunet, ME Greenberg - Genes & development, 1999 - genesdev.cshlp.org
The programmed cell death that occurs as part of normal mammalian development was first
observed nearly a century ago (Collin 1906). It has since been established that …

A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1

X **a, X Li, F Li, X Wu, M Zhang, H Zhou, N Huang… - Molecular cancer, 2019 - Springer
Abstract Background The RTK/PI3K/AKT pathway plays key roles in the development and
progression of many cancers, including GBM. As a regulatory molecule and a potential drug …

The B-cell receptor signaling pathway as a therapeutic target in CLL

JA Woyach, AJ Johnson, JC Byrd - Blood, The Journal of the …, 2012 - ashpublications.org
Targeted therapy with imatinib and other selective tyrosine kinase inhibitors has transformed
the treatment of chronic myeloid leukemia. Unlike chronic myeloid leukemia, chronic …

The mTORC2 signaling network: targets and cross-talks

A Ragupathi, C Kim, E Jacinto - Biochemical Journal, 2024 - portlandpress.com
The mechanistic target of rapamycin, mTOR, controls cell metabolism in response to growth
signals and stress stimuli. The cellular functions of mTOR are mediated by two distinct …

PI (3, 4, 5) P3 engagement restricts Akt activity to cellular membranes

M Ebner, I Lučić, TA Leonard, I Yudushkin - Molecular cell, 2017 - cell.com
Protein kinase B/Akt regulates cellular metabolism, survival, and proliferation in response to
hormones and growth factors. Hyperactivation of Akt is frequently observed in cancer, while …

Activation of AKT kinases in cancer: implications for therapeutic targeting

A Bellacosa, CC Kumar, A Di Cristofano… - Advances in cancer …, 2005 - Elsevier
The AKT1, AKT2, and AKT3 kinases have emerged as critical mediators of signal
transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3 …